BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 6755247)

  • 1. Hepatitis B vaccine in medical staff of hemodialysis units: efficacy and subtype cross-protection.
    Szmuness W; Stevens CE; Harley EJ; Zang EA; Alter HJ; Taylor PE; DeVera A; Chen GT; Kellner A
    N Engl J Med; 1982 Dec; 307(24):1481-6. PubMed ID: 6755247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis B vaccine in patients receiving hemodialysis. Immunogenicity and efficacy.
    Stevens CE; Alter HJ; Taylor PE; Zang EA; Harley EJ; Szmuness W
    N Engl J Med; 1984 Aug; 311(8):496-501. PubMed ID: 6235453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis B vaccine: demonstration of efficacy in a controlled clinical trial in a high-risk population in the United States.
    Szmuness W; Stevens CE; Harley EJ; Zang EA; Oleszko WR; William DC; Sadovsky R; Morrison JM; Kellner A
    N Engl J Med; 1980 Oct; 303(15):833-41. PubMed ID: 6997738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis B in haemodialysis: vaccination against HBS antigen.
    Crosnier J
    Proc Eur Dial Transplant Assoc; 1981; 18():231-40. PubMed ID: 7036150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune response to hepatitis B vaccine in the staff of a hemodialysis unit.
    Landa L; Rattoni N; Lehne C; Trujillo J; Landa E
    Arch Invest Med (Mex); 1984; 15(2):133-8. PubMed ID: 6487003
    [No Abstract]   [Full Text] [Related]  

  • 6. Hepatitis B vaccine in health care personnel: safety, immunogenicity, and indicators of efficacy.
    Dienstag JL; Werner BG; Polk BF; Snydman DR; Craven DE; Platt R; Crumpacker CS; Ouellet-Hellstrom R; Grady GF
    Ann Intern Med; 1984 Jul; 101(1):34-40. PubMed ID: 6233921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term immunogenicity and efficacy of hepatitis B vaccine in homosexual men.
    Hadler SC; Francis DP; Maynard JE; Thompson SE; Judson FN; Echenberg DF; Ostrow DG; O'Malley PM; Penley KA; Altman NL
    N Engl J Med; 1986 Jul; 315(4):209-14. PubMed ID: 2941687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune response to hepatitis B vaccine in staff and patients in renal dialysis units.
    Bergamini F; Zanetti AR; Ferroni P; Tanzi E; Minetti L; Perego A; Civati G; Mecca G; Licini R; Sereni F
    J Infect; 1983 Jul; 7 Suppl 1():35-40. PubMed ID: 6674368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized double-blind clinical trial of a mammalian cell-derived recombinant DNA hepatitis B vaccine compared with a plasma-derived vaccine.
    Halliday ML; Rankin JG; Bristow NJ; Coates RA; Corey PN; Strickler AC
    Arch Intern Med; 1990 Jun; 150(6):1195-200. PubMed ID: 2141247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The safety and efficacy of GM-CSF as an adjuvant in hepatitis B vaccination of chronic hemodialysis patients who have failed primary vaccination.
    Evans TG; Schiff M; Graves B; Agosti J; Barritt ML; Garner D; Holley JL
    Clin Nephrol; 2000 Aug; 54(2):138-42. PubMed ID: 10968690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Humoral response in health service personnel after administration of hepatitis B vaccine Gen-H-B-Vax].
    Juszczyk J; Rokossowski H; Krajewska M; Piatek A
    Przegl Epidemiol; 1991; 45(1-2):11-6. PubMed ID: 1839075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase I clinical trial in healthy adults of a nasal vaccine candidate containing recombinant hepatitis B surface and core antigens.
    Betancourt AA; Delgado CA; Estévez ZC; Martínez JC; Ríos GV; Aureoles-Roselló SR; Zaldívar RA; Guzmán MA; Baile NF; Reyes PA; Ruano LO; Fernández AC; Lobaina-Matos Y; Fernández AD; Madrazo AI; Martínez MI; Baños ML; Alvarez NP; Baldo MD; Mestre RE; Pérez MV; Martínez ME; Escobar DA; Guanche MJ; Cáceres LM; Betancourt RS; Rando EH; Nieto GE; González VL; Rubido JC
    Int J Infect Dis; 2007 Sep; 11(5):394-401. PubMed ID: 17257877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A controlled clinical trial of the efficacy of the hepatitis B vaccine (Heptavax B): a final report.
    Szmuness W; Stevens CE; Zang EA; Harley EJ; Kellner A
    Hepatology; 1981; 1(5):377-85. PubMed ID: 7030902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hepatitis B vaccine trial in healthy adults - an immunogenicity study (author's transl)].
    Zachoval R; Frösner G; Deinhardt F
    MMW Munch Med Wochenschr; 1981 Oct; 123(40):1506-8. PubMed ID: 6795461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of perinatal acquisition of hepatitis B virus carriage using vaccine: preliminary report of a randomized, double-blind placebo-controlled and comparative trial.
    Xu ZY; Liu CB; Francis DP; Purcell RH; Gun ZL; Duan SC; Chen RJ; Margolis HS; Huang CH; Maynard JE
    Pediatrics; 1985 Nov; 76(5):713-8. PubMed ID: 3903646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prevention of hepatitis B with vaccine. Report of the centers for disease control multi-center efficacy trial among homosexual men.
    Francis DP; Hadler SC; Thompson SE; Maynard JE; Ostrow DG; Altman N; Braff EH; O'Malley P; Hawkins D; Judson FN; Penley K; Nylund T; Christie G; Meyers F; Moore JN; Gardner A; Doto IL; Miller JH; Reynolds GH; Murphy BL; Schable CA; Clark BT; Curran JW; Redeker AG
    Ann Intern Med; 1982 Sep; 97(3):362-6. PubMed ID: 6810736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Efficacy and tolerance of hepatitis B vaccination in medical personnel and hemodialysis patients].
    Horak W; Leithner C; Kemenesi W; Pinggera W
    Wien Klin Wochenschr; 1984 Feb; 96(4):161-5. PubMed ID: 6231779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis B and the dental profession: response to hepatitis B vaccine in Canadian dental personnel. A study by the Canadian Red Cross Collaborative Group.
    Larke RP; Bouchard SA; Buchner BK; Derrick JB; McSheffrey JB; Vas SI
    J Infect; 1983 Jul; 7 Suppl 1():27-33. PubMed ID: 6674366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune response to a heat-inactivated hepatitis B vaccine in patients undergoing hemodialysis. Enhancement of the response by increasing the dose of hepatitis B surface antigen from 3 to 27 micrograms.
    Lelie PN; Reesink HW; de Jong-van Manen ST; Dees PJ; Reerink-Brongers EE
    Arch Intern Med; 1985 Feb; 145(2):305-9. PubMed ID: 3977491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis B vaccine: clinical trials in high-risk settings in France. (September 1975-September 1982).
    Goudeau A; Dubois F; Barin F; Dubois MC; Coursaget P
    Dev Biol Stand; 1983; 54():267-84. PubMed ID: 6228468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.